The Nifty Pharma index closed 0.4 per cent down at 13993.2.

Rohit Singre, senior technical analyst at LKP Securities said the index has formed a good support zone around 17,850-17,780 levels and holding above the said range can help it trade with a positive bias.

“Technology is becoming an important differentiator for these banks in terms of how they service the customers and how they look at the business opportunities.”

The drugmaker reported a 12.5 per cent YoY rise in its consolidated revenue from operations to Rs 9,625.9 crore for the reported quarter, which was also above Street’s estimate.

Analysts believe momentum in Mumbai housing sales will continue going ahead in the festive season. While matching the FY21 performance in absence of a stamp duty relief is a tall order, they believe the housing market is reviving nonetheless.

Net interest income (NII) stood at Rs 3,523 crore for the quarter Q2FY22. On a sequential basis, it increased by 12.06 per cent from Rs 3,144 crore in quarter ended June 2021, the bank said.

The SQUID token turned an investment of Rs 1,000 into Rs 23 lakh within a week. But it could not fetch even a penny about 24 hours after reaching the peak.

Revenue from operations during the quarter under review stood at Rs 1,058.30 crore as against Rs 1,009.45 crore in the corresponding period a year ago.

In the international market, both gold and silver were trading flat at USD 1,793 per ounce and USD 23.95 per ounce, respectively.

“The percentage of non-performing loans has come down as we have seen about a 25 to 27 bps improvement in the level of non-performing loans. ”